Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FAAZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,984
Award facts
- Contract value 100% obligated
- $10,984.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,984.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment. This non-competitive delivery order was executed on October 31, 2025, with an ultimate completion date of November 3, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain and has demonstrated substantial capability in fulfilling DLA procurement requirements across multiple therapeutic domains. The company's federal contract portfolio encompasses a diverse range of brand-name and generic medications, vaccines, and specialized medical supplies, with previous awards ranging from minimal to over $45,000 in value. This delivery order exemplifies the DLA's reliance on AmerisourceBergen's established logistics infrastructure and inventory management capabilities to support military healthcare operations with critical pharmaceutical products on an expedited timeline.
Quick answers
Who was awarded contract SPE2DB26FAAZ5?
SPE2DB26FAAZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FAAZ5 worth?
The government has obligated $10,984 on SPE2DB26FAAZ5.
Is contract SPE2DB26FAAZ5 an order under another contract?
Yes. SPE2DB26FAAZ5 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FAAZ5 competed?
The extent of competition for SPE2DB26FAAZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award